We specialize in designing and producing therapeutic glycoproteins with optimized glycosylation patterns to enhance efficacy, stability, and pharmacokinetics.
There is no product in the shopping cart, buy it!
Mannuronate C5-epimerase is a pivotal Glycosyl Functional Enzyme in the biosynthesis of alginate, a natural polysaccharide widely found in brown seaweeds and certain bacteria. This Epimerase catalyzes the epimerization of the C5 position of mannuronic acid residues within the alginate polymer chain, converting them into guluronic acid. This structural modification is crucial as it influences the physical and chemical properties of alginate, such as its gel-forming ability and viscosity. Mannuronate C5-epimerase plays a significant role in tailoring alginate for various industrial applications, including food, pharmaceuticals, and biotechnology.
Fig.1 The structure of alginate and the functions of ManC5-Es.1
Are you currently facing high batch-to-batch variability in seaweed-derived alginates, limited mechanical strength in tissue scaffolds, or poor cell viability in 3D bioprinting? Creative Biolabs provides a definitive solution for organizations demanding absolute control over biopolymer behavior. Our bespoke epimerization service translates raw seaweed extracts into sophisticated, high-performance biomaterials essential for advanced tissue engineering and targeted drug delivery systems. By utilizing our proprietary library, we help you overcome natural variability to achieve the specific G-block architectures required for mechanical stability and precise diffusion.
Discover How We Optimize Production Scalability
Begin by isolating the gene responsible for encoding mannuronate C5-epimerase from its natural source. Utilize molecular cloning techniques to insert this gene into a high-efficiency expression vector, ensuring the codon usage is optimized for the selected host organism to enhance translation efficiency.
Carefully select a host organism based on its growth characteristics, ease of genetic manipulation, and ability to express heterologous proteins. Transform the host with the recombinant vector using established methods such as electroporation or chemical transformation, generating a genetically engineered strain capable of producing mannuronate C5-epimerase.
Cultivate the transformed host in a bioreactor under strictly controlled conditions. Optimize parameters such as temperature, pH, dissolved oxygen levels, and nutrient supply to maximize cell growth and enzyme expression. Employ fed-batch or continuous fermentation strategies as needed to achieve high cell densities and enzyme yields.
Once fermentation is complete, harvest the cells using centrifugation or filtration techniques. Subsequently, lyse the cells using mechanical methods or chemical agents to release the intracellular mannuronate C5-epimerase.
Purify the enzyme from the cell lysate using a combination of chromatography techniques. Initially, employ ion exchange chromatography to separate the enzyme based on its charge properties. Follow this with affinity chromatography if a specific tag was incorporated during gene cloning, or use size exclusion chromatography to further refine the purity. Perform dialysis or buffer exchange to prepare the enzyme for downstream applications.
Assess the purified enzyme's activity, stability, and yield using appropriate assays. Based on these results, optimize production parameters such as media composition, induction conditions, and purification strategies to enhance enzyme performance and scalability. Implement rigorous quality control measures to ensure consistency and reproducibility of the final enzyme product.
Fig.2 Production workflow of mannuronate C5-epimerase.
Regulatory-Friendly
"Using custom mannuronate C5-epimerase production in our research has significantly facilitated the development of reproducible bone marrow niche models."- 4 weeks ago, Dr. J** L**
Data-Comprehensive
"The ultra-low endotoxin levels in engineered mannuronate C5-epimerase facilitated our recent regulatory submission for a novel drug delivery system. Their NMR data packages are comprehensive and directly address the characterization by design requirements."- 2 weeks ago, Dr. R** M***
Collaborating to Meet Global Demand Effectively
A: Enzymatic modification is highly regio-specific and occurs under mild aqueous conditions, preserving the natural polymer backbone. Unlike chemical methods, it avoids toxic catalysts and maintains the biocompatibility required for clinical implants.
A: Yes. Our Tier 2 modification service is specifically designed to upgrade commercial seaweed alginates, allowing you to reach G-contents that are rarely found in nature.
A: Absolutely. We utilize high-cell-density fermentation in E. coli to produce recombinant modules at scales sufficient for both R&D and pilot-scale manufacturing.
A: Our preliminary consultation includes a module selection phase where we analyze your target mechanical profile and recommend the specific catalytic/regulatory modules required to achieve it.
We specialize in designing and producing therapeutic glycoproteins with optimized glycosylation patterns to enhance efficacy, stability, and pharmacokinetics.
We develop high-affinity, carbohydrate-specific antibodies for diagnostics and targeted therapies, leveraging advanced screening and engineering to ensure specificity against complex glycan structures.
Creative Biolabs provides the most advanced platform for custom mannuronate C5 epimerase production. By combining 20 years of biocatalysis expertise with cutting-edge biosynthetic research, we empower our clients to bypass the biological lottery of seaweed and create precision-engineered, regulatory-ready biomaterials for the future of medicine. Ready to take control of your biopolymer architecture? Our specialist team is available for technical consultations regarding your specific project needs. Contact us now!
Reference